Guggenheim Capital LLC Ironwood Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 100,251 shares of IRWD stock, worth $403,009. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,251

Previous 89,944 11.46%

Holding current value

$403,009

Previous $586,000 29.69%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.93 - $7.04 $40,506 - $72,561	10,307 Added 11.46%	100,251 $412,000
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $71,167 - $109,811	12,754 Added 16.52%	89,944 $586,000
Q1 2024 May 14, 2024	SELL	$8.32 - $15.45 $1.36 Million - $2.53 Million	-163,681 Reduced 67.95%	77,190 $672,000
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $132,060 - $172,926	-15,024 Reduced 5.87%	240,871 $2.76 Million
Q3 2023 Nov 14, 2023	BUY	$8.25 - $11.35 $74,786 - $102,887	9,065 Added 3.67%	255,895 $2.46 Million
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $732,785 - $841,614	-72,553 Reduced 22.72%	246,830 $2.63 Million
Q1 2023 May 10, 2023	SELL	$10.37 - $12.56 $342,790 - $415,183	-33,056 Reduced 9.38%	319,383 $3.36 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $146,510 - $183,951	-14,799 Reduced 4.03%	352,439 $4.37 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $1.04 Million - $1.27 Million	102,562 Added 38.75%	367,238 $3.81 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $1.84 Million - $2.11 Million	166,184 Added 168.73%	264,676 $3.05 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $87,447 - $106,156	-8,242 Reduced 7.72%	98,492 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $1.16 Million - $1.49 Million	106,734 New	106,734 $1.25 Million
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $1.42 Million - $2.94 Million	-182,126 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $142,871 - $176,217	9,984 Added 5.8%	182,126 $3.36 Million
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $199,122 - $272,678	-16,832 Reduced 8.91%	172,142 $3.29 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $48,660 - $59,590	4,372 Added 2.37%	188,974 $2.92 Million
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $580,615 - $696,165	-47,748 Reduced 20.55%	184,602 $2.77 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $2.8 Million - $3.46 Million	232,350	232,350 $3.66 Million

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $616M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Ironwood Pharmaceuticals Inc Transaction History